D. E. Shaw & Co., Inc. Applied Molecular Transport Inc. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.35 - $1.26 $35,820 - $128,952	-102,343 Reduced 60.89%	65,743 $27,000
Q3 2022 Nov 14, 2022	BUY	$1.12 - $3.12 $14,693 - $40,931	13,119 Added 8.47%	168,086 $164,000
Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $206,097 - $571,248	-74,673 Reduced 32.52%	154,967 $451,000
Q1 2022 May 16, 2022	BUY	$5.63 - $13.88 $674,564 - $1.66 Million	119,816 Added 109.1%	229,640 $1.73 Million
Q4 2021 Feb 14, 2022	BUY	$13.23 - $26.05 $772,327 - $1.52 Million	58,377 Added 113.47%	109,824 $1.54 Million
Q3 2021 Nov 15, 2021	BUY	$25.87 - $46.61 $1.33 Million - $2.4 Million	51,447 New	51,447 $1.33 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.